WINDLAS BIOTECH
|
The Current P/S Ratio of WINDLAS BIOTECH is 1.78.
| Share Price | ₹730.5 | Mar 09,2026 |
| Market Cap | ₹1,541.4 Cr | |
| Sales-TTM | ₹868.3 Cr | TTM-Consolidated Results |
| Price/Sales | 1.78x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of WINDLAS BIOTECH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹1,541.4 Cr] as on Mar 09,2026
(/) Sales [ ₹868.3 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.78x ]
Thus, for WINDLAS BIOTECH , the investors are currently willing to pay '1.78 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of WINDLAS BIOTECH !
The chart below summarizes the trend in P/S Ratio of WINDLAS BIOTECH over the last five years.
Historical PS (Price/Sales) ratio chart of WINDLAS BIOTECH
PS Ratio Performance Analysis for WINDLAS BIOTECH
- WINDLAS BIOTECH 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 1.29x.
- WINDLAS BIOTECH 's operated at median p/e ratio of 0.98x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, WINDLAS BIOTECH 's p/e ratio peaked in Mar2025 at 2.87x.
- WINDLAS BIOTECH 's p/e ratio hit its five-year low in Mar2021 of 0x.
How does WINDLAS BIOTECH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| WINDLAS BIOTECH | 868.3 | 1.78 | 1,541.4 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.63 | 433,704.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.31 | 168,223.0 |
| CIPLA LTD | 28,351.1 | 3.78 | 107,043.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.61 | 147,928.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.10 | 107,368.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.41 | 89,250.5 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.50 | 91,431.5 |
| LUPIN LTD | 26,150.5 | 4.02 | 105,198.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.18 | 72,426.0 |
| ABBOTT INDIA LTD | 6,824.1 | 8.46 | 57,710.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs WINDLAS BIOTECH 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.78x |
| Max industry PS | 16.31x |
| Median industry PS | 4.02x |
| Average industry PS | 6.25x |
You may also like the below Video Courses